Lilly to Icos: Merry Christmas, you're fired

When Eli Lilly announced last October that it was buying Icos, it made no secret of the fact that it was primarily interested in gaining complete control of their jointly marketed ED drug. It turns out that they're not at all interested in the company's workers. All 700 people employed at Icos' Bothell, WA offices have been notified that they will be laid off once the $2.1 billion buyout is approved by shareholders. The vote is scheduled for next Tuesday, just a week before Christmas.

- read the AP report on the company-wide pink slip

Suggested Articles

Bausch Health is paying $10 million upfront for the option to acquire Allegro Ophthalmics’ eye disease assets, with a promise of $40 million to come.

Anthony Coyle, Ph.D., has signed up to run Repertoire Immune Medicines’ R&D.

The IPO haul will set Kronos up to start a registrational phase 2/3 trial of a first-line AML drug licensed from Bischofberger's former employer.